Navigating Glofitimab: Excitement and Caution

This chapter explores the recent addition of glofitimab to the NCCN guidelines for mantle cell lymphoma treatment, highlighting both the promise of new options and concerns regarding cytokine release syndrome. It emphasizes the need for thorough safety evaluations, proper guidelines, and the role of pharmacists in community practices to enhance patient outcomes.